Invited commentary.
Wan
Song
S
Division of Cardiothoracic Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China. swan@cuhk.edu.hk
D001786:Blood Glucose / Q000032:analysis; D001026:Coronary Artery Bypass / Q000009:adverse effects / Q000379:methods*; D004305:Dose-Response Relationship, Drug; D005500:Follow-Up Studies; D006801:Humans; D007328:Insulin / Q000008:administration & dosage* / Q000097:blood; D007430:Intraoperative Care; D015428:Myocardial Reperfusion Injury / Q000517:prevention & control; D011183:Postoperative Complications / Q000517:prevention & control; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D018746:Systemic Inflammatory Response Syndrome / Q000209:etiology / Q000517:prevention & control*; D016896:Treatment Outcome
D001786:Blood Glucose; D007328:Insulin